Surapol Issaragrisil

(Learn how and when to remove this message)
Surapol Issaragrisil
MD, FRCP, FACP, FRCPA, FRCPath
สุรพล อิสรไกรศีล
Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
President of the Royal Society (Thailand)
In office
12 April 2019 – 11 April 2021
Preceded bySobha Chupikulchai Spielmann
Succeeded bySuraphon Wiroonrak
President of the Royal Society (Thailand)
In office
12 April 2023 – Present
Preceded bySuraphon Wiroonrak
Personal details
Born (1950-07-18) July 18, 1950 (age 74)
Damnoen Saduak, Ratchaburi, Thailand
SpouseRattana Issaragrisil
Children3
Alma materMahidol University (MD)
ProfessionMedical Doctor
Academic

Surapol Issaragrisil (Thai: สุรพล อิสรไกรศีล, RTGSSuraphon Itsarakraisin; born 18 July 1950) is medical doctor and professor of medicine at Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University. He is an expert at hematology, bone marrow transplantation, and blood stem cells transplantation.[1][2][3]

Early life and education

Surapol was born in Damnoen Saduak District, Ratchaburi Province, Thailand. He studied his secondary education from Metreechunhawanvittayalai School at Bang Khonthi District, Samut Songkram Province, and then pursued his high school at Trium Udom Suksa school in Bangkok before having his bachelor's degree at medicine, Faculty of Medicine Siriraj Hospital in 1974. Later, he continued to study in order to have his Certified Board at Internal Medicine in 1978, add his research fellow from Department of Clinical Physiology at University of Ulm in Germany in 1982, take his Certified Board at Hematology in 1984 and get his clinical fellow, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, US, in 1985.[4]

Position

Membership and fellowship

Decorations

Honors and awards

References

  1. ^ Scopus Review: Document details - Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues
  2. ^ Scopus Review: Document details - Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control
  3. ^ Scopus Review: Document details - Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells
  4. ^ Surapol Issaragris from SISCR
  5. ^ Siriraj Center of Excellence for Stem Cell Research